117 related articles for article (PubMed ID: 32791153)
1. Evaluation of immune infiltrating of thyroid cancer based on the intrinsic correlation between pair-wise immune genes.
Jia M; Li Z; Pan M; Tao M; Lu X; Liu Y
Life Sci; 2020 Oct; 259():118248. PubMed ID: 32791153
[TBL] [Abstract][Full Text] [Related]
2. Identification of a Recurrence Signature and Validation of Cell Infiltration Level of Thyroid Cancer Microenvironment.
Zhang L; Wang Y; Li X; Wang Y; Wu K; Wu J; Liu Y
Front Endocrinol (Lausanne); 2020; 11():467. PubMed ID: 32793117
[TBL] [Abstract][Full Text] [Related]
3. Immune cell infiltrate-associated dysregulation of DNA repair machinery may predispose to papillary thyroid carcinogenesis.
Nicolson NG; Brown TC; Korah R; Carling T
Surgery; 2020 Jan; 167(1):66-72. PubMed ID: 31439400
[TBL] [Abstract][Full Text] [Related]
4. Identification of Key Genes in Thyroid Cancer Microenvironment.
Zhao K; Yang H; Kang H; Wu A
Med Sci Monit; 2019 Dec; 25():9602-9608. PubMed ID: 31839674
[TBL] [Abstract][Full Text] [Related]
5. Immune gene signature delineates a subclass of thyroid cancer with unfavorable clinical outcomes.
Zhi J; Yi J; Tian M; Wang H; Kang N; Zheng X; Gao M
Aging (Albany NY); 2020 Apr; 12(7):5733-5750. PubMed ID: 32240105
[TBL] [Abstract][Full Text] [Related]
6. Network-based meta-analysis in the identification of biomarkers for papillary thyroid cancer.
Zhao H; Li H
Gene; 2018 Jun; 661():160-168. PubMed ID: 29625265
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of an individualized diagnostic signature in thyroid cancer.
Han LO; Li XY; Cao MM; Cao Y; Zhou LH
Cancer Med; 2018 Apr; 7(4):1135-1140. PubMed ID: 29522282
[TBL] [Abstract][Full Text] [Related]
8. The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management.
Panebianco F; Mazzanti C; Tomei S; Aretini P; Franceschi S; Lessi F; Di Coscio G; Bevilacqua G; Marchetti I
BMC Cancer; 2015 Nov; 15():918. PubMed ID: 26581891
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic application of RNA sequencing in patients with thyroid cancer: an analysis of 851 variants and 133 fusions in 524 genes.
Pagan M; Kloos RT; Lin CF; Travers KJ; Matsuzaki H; Tom EY; Kim SY; Wong MG; Stewart AC; Huang J; Walsh PS; Monroe RJ; Kennedy GC
BMC Bioinformatics; 2016 Jan; 17 Suppl 1(Suppl 1):6. PubMed ID: 26818556
[TBL] [Abstract][Full Text] [Related]
10. Expression based biomarkers and models to classify early and late-stage samples of Papillary Thyroid Carcinoma.
Bhalla S; Kaur H; Kaur R; Sharma S; Raghava GPS
PLoS One; 2020; 15(4):e0231629. PubMed ID: 32324757
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment.
Li ZX; Zheng ZQ; Wei ZH; Zhang LL; Li F; Lin L; Liu RQ; Huang XD; Lv JW; Chen FP; He XJ; Guan JL; Kou J; Ma J; Zhou GQ; Sun Y
Theranostics; 2019; 9(25):7648-7665. PubMed ID: 31695792
[TBL] [Abstract][Full Text] [Related]
12. Identification of key genes and pathways of thyroid cancer by integrated bioinformatics analysis.
Liu L; He C; Zhou Q; Wang G; Lv Z; Liu J
J Cell Physiol; 2019 Dec; 234(12):23647-23657. PubMed ID: 31169306
[TBL] [Abstract][Full Text] [Related]
13. A novel gene panel for prediction of lymph-node metastasis and recurrence in patients with thyroid cancer.
Ruiz EML; Niu T; Zerfaoui M; Kunnimalaiyaan M; Friedlander PL; Abdel-Mageed AB; Kandil E
Surgery; 2020 Jan; 167(1):73-79. PubMed ID: 31711617
[TBL] [Abstract][Full Text] [Related]
14. Emerging immune gene signatures as prognostic or predictive biomarkers in breast cancer.
Kwon MJ
Arch Pharm Res; 2019 Nov; 42(11):947-961. PubMed ID: 31707598
[TBL] [Abstract][Full Text] [Related]
15. A novel RNA sequencing-based risk score model to predict papillary thyroid carcinoma recurrence.
He J; Tian Z; Yao X; Yao B; Liu Y; Yang J
Clin Exp Metastasis; 2020 Apr; 37(2):257-267. PubMed ID: 31792675
[TBL] [Abstract][Full Text] [Related]
16. Long Non-Coding RNA ZFAS1 as a Novel Potential Biomarker for Predicting the Prognosis of Thyroid Cancer.
Han CG; Huang Y; Qin L
Med Sci Monit; 2019 Apr; 25():2984-2992. PubMed ID: 31012438
[TBL] [Abstract][Full Text] [Related]
17. Assessment of risk based on variant pathways and establishment of an artificial neural network model of thyroid cancer.
Zhao Y; Zhao L; Mao T; Zhong L
BMC Med Genet; 2019 May; 20(1):92. PubMed ID: 31138213
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Implications of Heterogeneity in Intra-tumoral Immune Composition for Recurrence in Early Stage Lung Cancer.
Mony JT; Schuchert MJ
Front Immunol; 2018; 9():2298. PubMed ID: 30374348
[No Abstract] [Full Text] [Related]
19. Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma.
Wang WQ; Liu L; Xu HX; Wu CT; Xiang JF; Xu J; Liu C; Long J; Ni QX; Yu XJ
Br J Surg; 2016 Aug; 103(9):1189-99. PubMed ID: 27256393
[TBL] [Abstract][Full Text] [Related]
20. Automatic cancer tissue detection using multispectral photoacoustic imaging.
Jnawali K; Chinni B; Dogra V; Rao N
Int J Comput Assist Radiol Surg; 2020 Feb; 15(2):309-320. PubMed ID: 31865531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
